title: Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials.
abstract: BACKGROUND
  Perioperative pathologic microvascular bleeding is associated with increased morbidity and mortality and could be reduced by hemostatic drugs. At the same time, safety concerns regarding existing hemostatic agents include excess mortality. Numerous trials investigating desmopressin have lacked power to detect a beneficial effect on transfusion of blood products. The authors performed a meta-analysis of 38 randomized, placebo-controlled trials (2,488 patients) investigating desmopressin in surgery and indicating at least perioperative blood loss or transfusion of blood products.
  
  
  METHODS
  Pertinent studies were searched in BioMed Central, CENTRAL, and PubMed (updated May 1, 2008). Further hand or computerized searches involved recent (2003-2008) conference proceedings.
  
  
  RESULTS
  In most of the included studies, 0.3 microg/kg desmopressin was used prophylactically over a 15- to 30-min period. In comparison with placebo, desmopressin was associated with reduced requirements of blood product transfusion (standardized mean difference = -0.29 [-0.52 to -0.06] units per patient; P = 0.01), which were more pronounced in the subgroup of noncardiac surgery and were without a statistically significant increase in thromboembolic adverse events (57/1,002 = 5.7% in the desmopressin group vs. 45/979 = 4.6% in the placebo group; P = 0.3).
  
  
  CONCLUSIONS
  Desmopressin slightly reduced blood loss (almost 80 ml per patient) and transfusion requirements (almost 0.3 units per patient) in surgical patients, without reduction in the proportion of patients who received transfusions. This meta-analysis suggests the importance of further large, randomized controlled studies using desmopressin in patients with or at risk of perioperative pathologic microvascular bleeding.
authors.affiliation: Department of Cardiothoracic Anesthesia and Intensive Care, Università Vita-Salute San Raffaele, Milano, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Crescenzi
authors.forename: Giovanni
authors.initials: G
authors.lastname: Landoni
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Biondi-Zoccai
authors.forename: Federico
authors.initials: F
authors.lastname: Pappalardo
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Nuzzi
authors.forename: Elena
authors.initials: E
authors.lastname: Bignami
authors.forename: Oliviero
authors.initials: O
authors.lastname: Fochi
authors.forename: Giulia
authors.initials: G
authors.lastname: Maj
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Calabrò
authors.forename: Marco
authors.initials: M
authors.lastname: Ranucci
authors.forename: Alberto
authors.initials: A
authors.lastname: Zangrillo
mesh_terms: D016063:Blood Loss, Surgical / Q000503:physiopathology / Q000517:prevention & control*; D001803:Blood Transfusion / Q000379:methods*; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology*; D006801:Humans; D055806:Microvessels / Q000187:drug effects / Q000502:physiology; D019990:Perioperative Care / Q000379:methods; D016032:Randomized Controlled Trials as Topic
chemical_list: D003894:Deamino Arginine Vasopressin